KYTX

NASDAQ · Biotechnology

Kyverna Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.87

+0.07 (+0.80%)

As of May 9, 1:50 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target -8.0% upside

Low Target $5.68

Average Target $8.16

High Target $10.96

Current Price $8.87

Current
$8.87

Target
$8.16

$5.68 $8.16 avg $10.96

Scenario Analysis

Bear Case

$5.68

-36.0%

Low target

Base Case

$8.16

-8.0%

Avg target

Bull Case

$10.96

+23.6%

High target

Risk/Reward

0.7x

Unfavorable

Price in Context

52-Week High

$13.67

-35.1% from high

52-Week Low

$1.95

+354.9% from low

Target vs 52W High

$8.16

-40.3% vs high

Next Earnings Report

May 19, 2026

until earnings

EPS Est: $-0.77

Earnings in 8 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%